StreetInsider.com News Articles

Form 8-K Editas Medicine, Inc. For: Jun 17

Thu, 18 Jun 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260618/26666501.html

Form 8-K Editas Medicine, Inc. For: Jun 17

Thu, 18 Jun 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260618/26666501.html

Form 4 Editas Medicine, Inc. For: Jun 03 Filed by: O'Neill Gilmore Neil

Fri, 05 Jun 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260605/26611635.html

Form 4 Editas Medicine, Inc. For: Jun 03 Filed by: O'Neill Gilmore Neil

Fri, 05 Jun 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260605/26611635.html

Form 4 Editas Medicine, Inc. For: Jun 03 Filed by: Parison Amy

Fri, 05 Jun 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260605/26611643.html

Form 4 Editas Medicine, Inc. For: Jun 03 Filed by: Parison Amy

Fri, 05 Jun 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260605/26611643.html

Form 4 Editas Medicine, Inc. For: Jun 03 Filed by: Burkly Linda

Fri, 05 Jun 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260605/26611621.html

Form 4 Editas Medicine, Inc. For: Jun 03 Filed by: Burkly Linda

Fri, 05 Jun 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260605/26611621.html

Form SCHEDULE 13G Editas Medicine, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Wed, 03 Jun 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260603/26599843.html

Form SCHEDULE 13G Editas Medicine, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Wed, 03 Jun 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260603/26599843.html

Form SCHEDULE 13G Editas Medicine, Inc. Filed by: TCG Crossover GP III, LLC

Wed, 03 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260603/26599092.html

Form SCHEDULE 13G Editas Medicine, Inc. Filed by: TCG Crossover GP III, LLC

Wed, 03 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260603/26599092.html

Form SCHEDULE 13G Editas Medicine, Inc. Filed by: Commodore Capital LP

Tue, 02 Jun 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260602/26593437.html

Form SCHEDULE 13G Editas Medicine, Inc. Filed by: Commodore Capital LP

Tue, 02 Jun 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260602/26593437.html

Form 144 Editas Medicine, Inc. Filed by: O'Neill Gilmore Neil

Fri, 29 May 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260529/26575983.html

Form 144 Editas Medicine, Inc. Filed by: O'Neill Gilmore Neil

Fri, 29 May 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260529/26575983.html

Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference

Thu, 28 May 2026 16:01:00 -0400

CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it will now present at the 2026 Jefferies Global Healthcare Conference at 2:00 p.m. ET on Thursday, June 4, 2026.

Updated Conference Details:

2026 Jefferies Global Healthcare Conference
Format: Presentation
Date: June 4, 2026
Time: 2:00 p.m. ET
New York, NY

To access the live webcast of Editas Medicine’s presentation, please visit the “Investors” section of the Company’s website at

Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference

Thu, 28 May 2026 16:01:00 -0400

Updated Conference Details:

2026 Jefferies Global Healthcare Conference
Format: Presentation
Date: June 4, 2026
Time: 2:00 p.m. ET
New York, NY

To access the live webcast of Editas Medicine’s presentation, please visit the “Investors” section of the Company’s website at

Increasing unusual option volume: CRSR NASA APPS EDIT AMPG MRLN AOSL EMN BEAM

Wed, 27 May 2026 10:14:17 -0400

Increasing unusual option volume: CRSR NASA APPS EDIT AMPG MRLN AOSL EMN BEAM

Form 424B5 Editas Medicine, Inc.

Tue, 26 May 2026 17:31:00 -0400

si-local-file:///var/storage/secattach/20260526/26551457.html

Form 424B5 Editas Medicine, Inc.

Tue, 26 May 2026 17:31:00 -0400

si-local-file:///var/storage/secattach/20260526/26551457.html

Form 8-K Editas Medicine, Inc. For: May 26

Tue, 26 May 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260526/26550752.html

Form 8-K Editas Medicine, Inc. For: May 26

Tue, 26 May 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260526/26550752.html

Editas Medicine prices $125 million public offering of stock and warrants

Tue, 26 May 2026 09:05:12 -0400

Editas Medicine Inc. (NASDAQ: EDIT) announced the pricing of a public offering of 55,555,556 shares of common stock and accompanying warrants at $2.25 per combined unit. The gene editing company expects to receive gross proceeds of approximately $125 million before underwriting fees and expenses.

Each warrant allows the purchase of one share at $3.50 and becomes exercisable immediately. The warrants expire either 30 days after the company announces Phase 1 clinical data for its EDIT-401 product candidate showing at least three patients with greater than 80% reduction in LDL-cholesterol compared to baseline, or three years from issuance, whichever occurs first.

If all

Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering

Tue, 26 May 2026 09:05:00 -0400

CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced the pricing of an underwritten public offering of 55,555,556 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 55,555,556 shares of common stock (or pre-funded warrants in lieu thereof). Each share of common stock and accompanying common stock warrant are being sold together at a combined public offering price of $2.25. The aggregate gross proceeds from the offering are expected to be approximately $125.0 million (assuming